Class act: Safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma

Mauricio Burotto*, Syed Abbas Ali, Geraldine O'sullivan Coyne

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Class act: Safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences